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Abstract: Background: There is a noticeable decline in the number of patients who undergo coronary artery revasculari-
zation procedures. The change is definite as it is reported by many centers around the world. This trend is of great concern 
to cardiac surgeons because of its impact on their practice, its adverse effect on training and the degree of uncertainty it 
throws into future of the specialty. 
Methods: The data of the cardiac catheterization laboratory at the King Fahad Cardiac Center in the period   
between 1986 and 2006 was examined looking at the changing pattern of management of patients who undergo   
cardiac catheterization.  
Results: In the early years, angioplasty was attempted in around 10% of patients leaving the rest for surgical consideration 
or medical therapy. Currently only 15% of patients who undergo selective coronary angiography are referred for surgery. 
The majority are offered angioplasty and stenting. The trend is towards more catheter-based interventions and less   
towards surgery.  
Conclusions: Our findings are in agreement with the general consensus about the specialty. Cardiac surgeons should  
perhaps consider acquiring new skills which may be outside the operating room. Adding catheter based intervention  
particularly in valves to cardiac surgery training would be a bonus for the future surgeons that will give them the   
necessary edge to meet the new challenges. It is incumbent on the leaders in the field to establish a clear strategy for the 
future. 
Mini-Abstract: Impact of advances in invasive cardiology on cardiac surgery, based on actual analysis of the pattern of  
referrals to surgery of over two decades.  
Key Words: Challenges facing cardiac surgery.  
INTRODUCTION 
  It is a sign of the times; angioplasty and stenting are   
taking the lion’s share of coronary artery disease manage-
ment. An important source for surgical material is diverted 
effectively reducing the surgical volume in many centers. 
The trend began with the introduction of percutaneous trans-
luminal coronary angioplasty (PTCA).and slowly but surely 
took hold. It proved to be not a passing wave as it was   
initially thought of; on the contrary, it took hold and gave 
rise to a string of interventions each one leading to further 
reduction of the surgeons’ fortune. The range of modalities 
in interventional cardiology is ever increasing affecting other 
areas of the cardiovascular disease. It is taking advantage of 
new technology and successfully applying it to manage other 
areas in the spectrum of heart disease. We looked at the trend 
at our institution over a period of 20 years and noticed a 
definite reduction in the number of surgical referrals espe-
cially for coronary artery disease. If it is any comfort, we are 
in the same boat with the other centers who are witnessing a 
dwindling cardiac surgery volume. In order to study the   
 
 
 
*Address correspondence to this author at the King Fahad Cardiac Center, 
College of Medicine, King Saud University, P.O. Box 7805, Riyadh, 11472, 
Saudi Arábia; Tel: 966 1 469-5275; Fax: 966 1 467-9493;  
E-mail: alsadd@hotmail.com 
dimensions of this change we looked at the factors that we 
believe are responsible for the shrinking volume. The root 
cause is not easy to pinpoint, but what is obvious is that 
while surgery remained stationary with a few cosmetic 
changes interventional catheterization underwent many revo-
lutions. Cardiologists appear to be more open-minded in 
embracing new technology as it comes out adding to their 
armamentarium. Their unparalleled enthusiasm led to the 
great leaps in catheter-based interventions. The solution to 
the challenges facing cardiac surgery is not an easy one; it 
would take an integrated effort and to a degree has to come 
from within the surgical community. Surgeons should 
probably re think their role, and perhaps would need to be 
involved much earlier than they do now so that they can 
have a better say in the management of patients. In addition, 
they should perhaps be more receptive to new technology 
and implement it much more readily once it is considered 
safe.  
MATERIAL AND METHODS 
  The cardiac catheterization laboratory (cath lab) data at 
the King Fahad Cardiac Center (The Center) for the period 
between August 1986 and December  2006 was examined. 
The aim was to analyze the pattern of disposition of patients 
following cardiac catheterization and any subsequent inter-
ventions. The total number of coronary angiograms per-
formed over this period of time is 14814. All the patients 22    The Open Cardiovascular Medicine Journal, 2009, Volume 3  Ahmed A. Alsaddique 
who underwent cardiac catheterization were under the care 
of cardiologists who were responsible for the subsequent
 
management decisions. Surgeons were consulted at the   
discretion of the cardiologists. Early on cardiologists insisted 
on having a surgical backup for every catheter-based inter-
vention. This is now history as most of percutaneous coro-
nary interventions (PCI) now are being performed without 
even informing the surgical team. They have a sense of secu-
rity because they are certain that their colleagues the   
surgeons are always there ready and willing to help if and 
when needed.  
Statistical Analysis 
  Data are expressed as mean +  standard deviation or   
median or range where appropriate. Analysis was performed 
by SPSS 11.5 (SPSS Inc. Chicago, Illinois). Significance 
was determined at p value of less than 0.05. All p values are 
two-sided and confidence intervals are 95%. 
RESULTS 
  At The Center the change began slowly to take hold, the 
surgeons were obviously in a state of denial until it became 
evident that the downturn was permanent. In additon, most 
of the cases that are referred for surgery have a variety of  
co-morbid conditions adding to the surgical risk. Interest-
ingly enough the problem is not unique to us as many other 
centers around the globe are experiencing a similar pattern 
[1, 2]. To validate this observation we examined the cardiac 
cath lab data for the period between August 1986 and   
December 2006. The current referral to surgery policy was 
compared to yesteryears referral practices. A total of 14814 
coronary angiographies were carried out during this period 
of time. A significant number of the patients 40% had diabe-
tes mellitus. The median hospital stay for cardiac catheteriza-
tion was 4.3 days. The males constituted 65.5% of the group 
while the females were 34.5%. The mean age for the group 
as a whole was 56.7 while the mean age for males alone was 
56.2 and for the females were 57.6. Left main disease was 
present in 1189 cases (8%), three vessel disease in 5037 
cases 34%, two vessel disease 2815 (19%) and single vessel 
disease in 2783 (18%). In 2962 patients (20%) the coronaries 
were found to be normal in spite of the convincing symp-
toms the patients had, leaving a total of 11852 patients’ data 
to analyze, Fig. (1). Of the remaining 11852 patients, a total 
of 7704 (65%) cases were primarily managed by angioplasty 
stenting. The rest 4148 patients (35%) underwent primarily 
CABG 73.7 % of them had multivessel disease involving the 
LAD; the rest had either a double vessel disease including 
the LAD or a significant LAD lesion alone that was felt to be 
significant. Median hospital stay for the surgery group was 
13.2 days.  
 
 
 
 
 
Fig. (1). The results of 14814 coronary angiograms. 
  In the angioplasty treated group acute coronary occlusion 
was encountered in 39 patients over the period of the study 
an incidence of 0.5% and was handled surgically in the early 
years; lately however, these complications are managed by 
deploying a bare metal or even a drug eluting stent leaving 
very little for surgery.  
  In the follow up of these patients, there was a 14.8%   
incidence of non-fatal myocardial infarction in the   
angioplasty treated group in the five years period that   
followed the intervention. In surgery, treated group 361   
patients (8.7%) experienced the same in a five years follow 
up (p  < 0.00001). Repeat catheterization was carried out   
because of recurrent stenosis causing symptoms in 27.4% of 
the angioplasty group and only in 7% of the patients who 
primarily had CABG, (p < 0.00001). During the of follow  
up period Coronary artery bypass grafting was eventually 
carried out on 19% of angioplasty stenting group because of 
recurrent stenosis not amenable to further interventions. The 
left main coronary hitherto untouchable by cardiologists is 
now being invaded in different clinical trials. At The Center, 
all left main disease is referred to surgery as the option   
of choice by the cardiologists. PCI for the left main was 
however carried out lately on five patients who posed unac-
ceptable surgical risk. A drug eluting stent was successfully 
deployed in four of them. One of these patients succumbed 
during the intervention. The short-term follow up is unevent-
ful. The success in these cases encouraged some cardiolo-
gists to recommend PCI for left main lesions that looked 
suitable for stenting citing the trials of other clinical centers 
in spite of the fact that stenting it with a DES is an off label 
use. [3, 4] .The evidence is compelling that CABG should 
indeed remain the preferred revascularization treatment in 
good surgical candidates with unprotected left main stenosis 
because of its substantial survival advantage and freedom 
from repeat intervention. PCI may be a reasonable option   
in those with isolated left main stenosis not involving the 
bifurcation or those in whom CABG is deemed too risky. 
However, PCI (with or without stents of any type) has   
not been shown to confer any survival advantage compared 
with medical therapy in any category of patients with stable 
coronary artery disease, and concerns remain over the risk  
of stent thrombosis with DES [5, 6].  
DISCUSSION 
 Procedures  involving  stent
 deployment are referred to as 
percutaneous coronary interventions (PCI) to distinguish 
them from the plain angioplasty; percutaneous transluminal 
coronary angioplasty (PTCA). Patients undergoing a percu-
taneous coronary intervention outnumber those with coro-
nary artery bypass surgery by a factor of 2 to 4. The default 
approach to PCI is the implantation of a drug-eluting stent 
(DES), in spite of the fact that it improves the results of   
balloon angioplasty only in about 25% of cases [7, 8] It is 
interesting to note that Andreas Gruentzig who is considered 
the father of interventional cardiology started the  first  
technical revolution in 1977 when He introduced balloon 
percutaneous transluminal coronary angioplasty (PTCA)   
and envisioned that only around 10 to 15% of patients with 
coronary artery disease were treatable by angioplasty [9]. 
The irony is that these figures represent the number of cases 
that are currently referred to surgery Fig. (2). The second 
revolution is probably the introduction in the mid 80’s of 
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lesion. The recent addition is the drug eluting stents (DES) 
also referred to as "coated stents" that were received with 
great enthusiasm leading to much publicity because of its off 
label use in about 60% of the time and is lately embroiled in 
serious controversy [10, 11]. As expected in order to make 
up for the shortcomings of the DES a fully bioabsorbable 
one is now being used. The short-term results have shown 
that the in-stent late loss was 0.44 mm at six months and the 
restenosis rate was 11.5% [12, 13]. 
 
 
 
 
 
 
 
 
 
Fig. (2). The changing pattern of referrals to surgery 1986-2006. 
  In view of the benefit, others and we have shown   
for coronary-artery bypass grafting, the real issue is   
why patients with symptoms and anatomy known to benefit 
from the procedure are still offered percutaneous coronary 
intervention [14]. Another point of equal interest is that   
patients with left ventricular ejection fraction >/=40% with a 
history of PCI prior to surgery had a worse outcome post 
CABG than those with no prior PCI. This is an important 
point to remember even though it is not certain if these   
results apply to drug eluting stents [15]. 
  PCI has its place, but it should be offered to a selected 
group of patients. As an initial management strategy in   
patients with
  stable coronary artery disease, PCI does   
not reduce the risk
 of death, myocardial infarction, or other 
major cardiovascular
 events when added to optimal medical 
therapy [16].  
  A considerable number of our patients are diabetics;   
the available evidence clearly shows the superiority of   
surgery in this subset of patients. It has been shown   
that CABG is superior to PCI in this subset of patients.   
More recently, it has been demonstrated that type 2 diabetes 
mellitus is a major risk factor for in-stent restenosis. This is 
related to the increased serum malondialdehyde-modified 
low-density lipoprotein (MDA-LDL) concentration.   
Increased levels of MDA-LDL might be a consequence of 
metabolic abnormalities caused by diabetes. It is thought that 
it may act as a growth factor for neointimal tissues inside the 
implanted stent [17]. This is yet another reason that surgery 
should be the option of choice for diabetic patients. 
  Surgery reduces the number of re-interventions compared 
to PCI with drug-eluting stents, CABG results in improved 
major adverse cardiovascular and cerebrovascular event   
in patients with 2- and 3-vessel coronary artery disease,   
primarily in those with underlying diabetes [18, 19]. 
  Our data showed improvement in the long-term survival 
for those who underwent surgery as the primary treatment 
option compared to those who underwent PCI as the primary 
therapeutic option but the difference is not as substantial as 
reported by others [20]. This is most probably due to the 
high incidence of diabetes mellitus in our patients.  
  Looking at other areas of cardiac surgery it is interesting 
to note that for a long time surgeons thought valves are their 
secure domain this was true until Zaibag [21] introduced 
percutaneous mitral valvotomy for mitral stenosis using 
double balloon. Many congenital heart diseases are now 
treated by the cardiologists (PDA, ASD, VSD, Coarctation, 
PS, distal pulmonary stenosis, and many others. Cardiolo-
gists have the patients and are armed with the latest catheter-
based advances their literature reveals how far ahead they 
are. Valvuloplasty for calcific aortic stenosis, percutaneous 
implantation of the pulmonic valve and mitral valvuloplasty 
among others are slowly but surely becoming a routine like 
coronary stenting [22-24]. 
  Percutaneous heart valve replacement and repair has 
emerged as an alternative to surgery. Thus one of the   
last remaining safe havens of surgery, treatment of valvular 
heart disease, is now being aggressively challenged by   
cardiologists. It seems that interventional Cardiology is   
now closer than ever to cardiac Surgery.  
COMMENT 
  Realistically cardiac surgery did not reach this stage   
over night; it was years in the making. In order to deal with 
this impact on surgery there must be a clear strategy through 
recognized bodies of the specialty to tackle this challenge 
because of its implication on training of future cardiac   
surgeons. For years, surgeons have quibbled over on or   
off-pump grafting, tissue or mechanical valves but the   
fundamental operations are unchanged. In the mean time, 
other fields of medicine have rapidly advanced.  
  Another issue that is responsible for decreasing caseload 
is the ever-increasing number of centers that have open-heart 
surgery programs. Left unchecked the current environment is 
not very conducive for training future cardiac surgeons, as 
most of the cases because of their complexity are usually 
done by the staff surgeons leaving very little for the trainees. 
The problem is multifactorial one and the approach should 
be with that understanding.  
1- One of the major problems is that cardiac surgeons   
practice as end of the line referral-based specialists. The 
patient is evaluated by a series of physicians before is  
finally seen by the cardiac surgeon. It is becoming   
clear that surgeons should have their input early on so 
that the patient becomes well informed and can make an 
intelligent choice. 
2- Even though cardiac surgeons are also general thoracic 
surgeons by training but they have given up all of   
thoracic surgery and some have even in the care of their 
patients in the ICU for the intensivist. In the heydays   
of cardiac surgery during the 70 cardiac surgeons gave 
away pacemakers.. In the 80s, Automatic Implantable 
Cardioverter Defibrillator (AICD) had the same fate.. A 
more rational approach is called for before making   
such decisions, as it is not an easy task regaining lost   
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3- It is time to refine those minimally invasive methods and 
try to apply them to as many procedures as possible.   
Robotic surgery should be encouraged and new applica-
tions for it are sought.. Given the choice of 2-5 year 80% 
success rate of a stent with antiplatelet treatment, versus a 
more than 90%, 15-20 year patency rate of LIMA-LAD 
without any drugs in a low risk patient, most cardiolo-
gist, and patients would opt for the stent.  
  Surgeons should come up with a truly minimally invasive 
CABG, like a totally endoscopic multi-vessel revasculariza-
tion, the patient is home in a couple of days and back to 
work in a week. To be realistic until that can be achieved 
more and more patients will opt for non-surgical treatment. 
Another approach is perhaps the hybrid myocardial revascu-
larization. It is based on the assumption that drug eluting 
stents (DES) are as good as vein grafts for type A or B coro-
nary artery lesions; but not as good as LIMA to the LAD 
which has 97% patency at10 years, it is the only graft that 
has shown survival benefits. Hybrid procedures are an attrac-
tive option for high-risk patients like the obese and those 
with COPD or for patients who seek a less traumatic revas-
cularization option. Hybrid coronary revascularization is a 
combination of minimally invasive coronary artery bypass 
grafting and percutaneous coronary intervention in patients 
with multivessel coronary artery disease. The concept is now 
10 years old. Implementation was slow, but major develop-
ments have taken place. The surgical part of the procedure 
can be performed in a totally endoscopic fashion. Intraopera-
tive graft angiography during coronary artery bypass grafting 
(CABG) procedures is one important benefit. The sequence 
of revascularization is not a settled issue yet. The surgeon 
can first complete the LIMA to LAD thus giving the cardi-
ologist a protected heart and then the cardiologist can subse-
quently proceed with the PCIs [23, 24]. 
4- Cardiac surgeons should be in the forefront of the evolv-
ing percutaneous valve procedures. The time to get in-
volved is now while the technique is still in its infancy. 
They understand valve repair and can therefore contrib-
ute to the development of these procedures. Percutaneous 
valve procedures require the expertise of different spe-
cialists (cardiac surgeon, interventional cardiologist, 
echocardiographist and anesthesiologist) working as a 
team. New horizons for cardiac surgeons are opening up 
[25]. The industry is aware that success of this technol-
ogy will depend on cooperation among the different spe-
cialists so they will spare no effort.  
5- The evidence about the superiority of surgical treatment 
of coronary artery disease compared to stenting   
angioplasty should be effectively used to spread the mes-
sage to the primary care physicians and even cardiolo-
gists. This was proven after ten randomized trials have
 
compared percutaneous coronary intervention and coro-
nary artery
 bypass grafting in patients with multivessel 
ischemic heart
 disease. Survival was rather
 similar with 
both interventions but surgery greatly reduced
 the need 
for further intervention (from 20% with PCI to 5% with 
coronary artery bypass grafting [26]. 
  One important fact remains and that is Cardiology itself 
is going through changes as the continued development of 
non-catheter based coronary imaging has the potential to 
radically alter the current cardiologist-cardiac surgeon rela-
tionship and makes surgical involvement in the patient care 
team essential [27, 28] . 
CONCLUSIONS 
  Cardiac surgery is facing major new challenges, but with 
the rapid advances in technology, there is great potential for 
innovation. As less invasive surgery gains popularity and 
surgeons change their role from being end of the line refer-
ral-based specialists to active participant the pre-operative 
decision-making, the field is poised for a renaissance and 
this could indeed prove to be to be an exciting time for heart 
surgery. This might sound too unreal for some; but if I could 
only stir a controversy, I would feel that I have accomplished 
my mission in initiating the much-needed debate. 
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